Shattuck Labs, Inc. (STTK): Revenue
$1.00M
Year ended 2025-12-31
$1.00M
Trailing 12 months to 2026-06-30
+15.3%
3-year compound annual growth
-36.8%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.00M | -82.5% | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | $5.72M | +245.3% | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | $1.66M | +154.1% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $652.0K | -97.8% | 2024-02-29, From 2022-01-01 |
| 2021-12-31 | $30.02M | +202.2% | 2023-02-23, From 2021-01-01 |
| 2020-12-31 | $9.93M | +0.5% | 2022-03-15, From 2020-01-01 |
| 2019-12-31 | $9.89M | n/a | 2021-03-16, From 2019-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $1.00M | -82.5% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $1.01M | +65.5% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $1.03M | n/m |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $917.0K | +44.0% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | $1.12M | +42.3% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $1.14M | -34.6% |
| Rallybio Corp (RLYB) | 2025-12-31 | $858.0K | +34.9% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $1.17M | -92.5% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $1.20M | -49.9% |
Compare STTK, SXTP, DARE, RFL side by side · Screen every company in Pharmaceutical Preparations ↗